Andreas Billich
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- Sphingolipid Metabolism and Signaling 38
- Chemical Synthesis and Analysis 3
-
- HIV/AIDS drug development and treatment 16
- Co-authors
- Thomas Baumruker (23 shared papers)Frédéric Bornancin (17 shared papers)Peter Nußbaumer (23 shared papers)Volker Brinkmann (4 shared papers)Josef G. Meingassner (7 shared papers)Diana Mechtcheriakova (12 shared papers)Nicole Urtz (10 shared papers)Fritz P. Schmook (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (10 papers)Journal of Medicinal Chemistry (10 papers)Biochemical and Biophysical Research Communications (5 papers)ChemMedChem (4 papers)Analytical Biochemistry (3 papers)
- Partner nations
- AustriaSwitzerlandGermany
In The Last Decade
Andreas Billich
135 papers receiving 7.3k citations
Andreas Billich's Hit Papers
Peers
Comparison fields: 5 of 108
- Pharmaceutical Science 325
- Virology 224
- Molecular Biology 2.5k
- Pathology and Forensic Medicine 449
- Dermatology 163
Countries citing papers authored by Andreas Billich
This map shows the geographic impact of Andreas Billich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Billich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Billich more than expected).
Fields of papers citing papers by Andreas Billich
This network shows the impact of papers produced by Andreas Billich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Billich. The network helps show where Andreas Billich may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Billich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Hit paper breakdown → | 2010 | 1084 |
| 2 | 2001 | 440 | |
| 3 | 2003 | 393 | |
| 4 | 2009 | 319 | |
| 5 | 2007 | 286 | |
| 6 | 2005 | 239 | |
| 7 | 2013 | 174 | |
| 8 | 1994 | 167 | |
| 9 | 1995 | 156 | |
| 10 | 2003 | 156 | |
| 11 | 2012 | 148 | |
| 12 | 1997 | 137 | |
| 13 | 2010 | 127 | |
| 14 | 2005 | 124 | |
| 15 | 2013 | 114 | |
| 16 | 2002 | 109 | |
| 17 | 2006 | 109 | |
| 18 | 1995 | 95 | |
| 19 | 2001 | 93 | |
| 20 | 2000 | 90 |
About Andreas Billich
Andreas Billich is a scholar working on Molecular Biology, Infectious Diseases, Virology, Genetics and Pharmaceutical Science, having authored 136 papers that have together received 7.6k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (38 papers), HIV/AIDS drug development and treatment (16 papers), Estrogen and related hormone effects (12 papers), HIV Research and Treatment (7 papers), Microbial Natural Products and Biosynthesis (5 papers), Advancements in Transdermal Drug Delivery (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Pharmaceutical Science (325 citations), Virology (224 citations), Molecular Biology (2.5k citations), Pathology and Forensic Medicine (449 citations) and Dermatology (163 citations). Andreas Billich has collaborated with scholars based in Austria, Switzerland and Germany. Frequent co-authors include Thomas Baumruker, Frédéric Bornancin, Peter Nußbaumer, Volker Brinkmann, Josef G. Meingassner, Diana Mechtcheriakova, Nicole Urtz, Fritz P. Schmook, Robert Schmouder and Pascale Burtin. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Biochemical and Biophysical Research Communications, ChemMedChem and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.